The global leader in healthcare naming!

Including nonproprietary (USAN/INN) names, drug brand names, medical device names, OTC product names, and COVID-19 vaccines, repurposed drugs, and diagnostics! We name over 75% of nonproprietary (USAN/INN) and drug brand name approvals worldwide!

1303
Healthcare Clients
4367
Total Healthcare Names
16
Obesity Names
Animal Health - 27
Antibiotic - 108
Antifungal - 28
Antiviral - 133
Antiviral/HIV - 52
Biologic Suffix - 62
Biosimilar Name - 29
Cardiovascular - 204
Class Name - 9
Clinical Trial Name - 117
Corporate Identity - 124
COVID-19 - 31
Covid-19 - 32
Dermatology - 146
Division Identity - 16
Endocrinology - 187
Gastrointestinal - 116
Hematology - 153
Identity Research - 15
Immunology - 255
Medical Device - 265
Men's Health - 11
Metabolic Disorders - 80
Musculoskeletal - 39
Nephrology - 34
Neurology - 380
Nutritional Agent - 53
Obesity - 16
Oncology - 794
Ophthalmology - 149
Oral Care - 8
OTC - 136
Pain & Inflammation - 169
Product Identity - 7
Program Name - 18
Respiratory - 212
Service Name - 17
Tagline - 11
Technology Name - 34
Urology - 26
USAN/INN - 1509
Vaccine - 106
Website - 22
Women's Health - 144
* Denotes a comprehensive report of the safety regulatory research prepared by B/DSI for submission of this name candidate to FDA, EMA, Health Canada, JMHLW, ANVISA, ROSZDRAVNADZOR, CDSCO, CFDA, KOREA MFDS, and/or other Regulatory Agencies.

CLIENTNAMECATEGORY
ALIZYMECETILISTAT Obesity
CITIUS PHARMASUPRENZA Obesity
EISAIBELVIQ *Obesity
GSKALLI Obesity
JANSSENefinopegdutide Obesity
NOVO NORDISKSAXENDA *Obesity
OREXIGEN THERAPEUTICSCONTRAVE *Obesity
PFIZERREDUX Obesity
RHYTHM PHARMACEUTICALSIMCIVREE *Obesity
RIEMSERALVALIN Obesity
ROCHEXENICAL Obesity
SANOFIACOMPLIA *Obesity
SHIONOGI PHARMAvelneperit Obesity
TAKEDAOBLEAN (オブリーン) Obesity
VIVUSQSYMIA *Obesity
ZAFGENaclimostat Obesity